We will use your email address only for sending you newsletters. Please see our Privacy Notice for details of your data protection rights.

A study by Johnson & Johnson shows work on a vaccine, which has been tested on monkeys, creates a strong immune response that protects against infection after a single dose.

Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer, Johnson & Johnson said: “We are excited to see these pre-clinical data because they show our SARS-CoV-2 vaccine candidate generated a strong antibody response and provided protection with a single dose.

“The findings give us confidence as we progress our vaccine development and upscale manufacturing in parallel, having initiated a Phase 1/2a trial in July with the intention to move into a Phase 3 trial in September.”

This is a breaking story…more to follow

Source: Read Full Article